You will be required to complete an information form for each patient. The 1st dose appointment will be scheduled for the selected time. The 2nd dose appointment will be scheduled by our team during the observation period 3 weeks after today's appointment. Your child will be eligible for a booster dose 5 months after receiving their 2nd dose. Talk to our team if your child is immunocompromised.

You will be required to complete an information form for each patient. The 2nd dose appointment will be scheduled for the selected time at least 3 weeks after receiving your 1st dose. Your child will be eligible for a booster dose 5 months after receiving their 2nd dose. Talk to our team if your child is immunocompromised.

You will be required to complete an information form for each patient. The 1st dose appointment will be scheduled for the selected time. The 2nd dose appointment will be scheduled by our team during the observation period 3 weeks after today's appointment. You or your child will be eligible for a booster dose 2 months after receiving the 2nd dose. Talk to our team if you or your child is immunocompromised.

You will be required to complete an information form for each patient. The 2nd dose appointment will be scheduled for the selected time at least 3 weeks after receiving your 1st dose. Your or your child will be eligible for a booster dose 2 months after receiving the 2nd dose. Talk to our team if you or your child is immunocompromised.

You will be required to complete an information form for each patient. The appointment will be scheduled for the selected time. You will be eligible for a booster dose 2 months after receiving this dose. Talk to our team if you are immunocompromised.

Note: On May 5, 2022 the U.S. Food and Drug Administration has limited the authorized use of the J&J COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the J&J COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine. This decision is related to the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets with onset of symptoms approximately one to two weeks following administration of the J&J COVID-19 Vaccine.

You will be required to complete an information form for each patient. The booster dose appointment will be scheduled for the selected time. Your child will be eligible for one dose 5 months after your 2nd dose. Talk to our team if your child is immunocompromised.